| Organism group |
Effect | |
| amphibian | suspected no endocrine effect
No inhibition of progesterone-induced oocyte maturation |
Show study |
| fish | Effect on estrogen
Upregulation of hepatic ER |
Show study |
| fish | Effect on estrogen
Induction of zonaradiata proteins |
Show study |
| fish | Effect on estrogen
Additivity in combination with butylbenzylphtalate or 17-beta-estradiol |
Show study |
| mammalian | suspected endocrine effect
Reduction in efferent duct epithelial cell height |
Show study |
| mammalian | Effect on retinoid hormone
38% inhibition of tritiated All trans retinoic acid binding to RAR |
Show study |
| mammalian | suspected no endocrine effect
Very weak inhibition of tritiated 17-beta-estradiol binding to ER (< 10%) |
Show study |
| mammalian | suspected no endocrine effect
Very weak inhibition of tritiated ORG2058 binding to PR (< 10%) |
Show study |
| mammalian | Effect on retinoid hormone
16% inhibition of tritiated All trans retinoic acid binding to RAR |
Show study |
| mammalian | Effect on androgen
15% inhibition of tritiated R1881 binding to AR |
Show study |
| mammalian | Effect on estrogen
RTA for ERalpha compared to radiolabeled 17-beta-estradiol (%): 61 |
Show study |
| mammalian | Effect on estrogen
RTA for ERbeta compared to radiolabeled 17-beta-estradiol (%): 57 |
Show study |
| mammalian | Effect on estrogen
RBA compared to radiolabeled 17-beta-estradiol (%): 0.02 |
Show study |
| mammalian | Effect on estrogen
RBA compared to radiolabeled 17-beta-estradiol (%): 0.07 |
Show study |
